Kohl P K, Meyer T F, Petzoldt D
Hautarzt. 1985 Jun;36(6):320-5.
Outer membrane components of Neisseria gonorrhoeae play an important role in the initial steps of infection. Precise knowledge about the surface antigens is needed for the development of a serotyping system and of a vaccine against local and systemic gonorrhea. Structure, antigenicity, and function of the best-known membrane components, i.e., lipopolysaccharide, protein I, protein II, protein III, and pili, are discussed. Lipopolysaccharide is a strong immunogen and induces bactericidal antibodies, but is unsuitable for use as a vaccine because of its toxicity. Protein I and protein III are stable proteins, not subject to antigenic variation. Antibodies against protein I, which are able to kill N. gonorrhoeae, are detectable in the serum of patients with disseminated gonococcal infection. Protein II and pili are highly variable antigens with constant, very slightly immunogenic regions. To interrupt the pathomechanism of gonococcal infection at different stages, future vaccines should contain more than one surface antigen.
淋病奈瑟菌的外膜成分在感染的初始阶段起着重要作用。开发针对局部和全身性淋病的血清分型系统及疫苗需要对表面抗原的精确了解。本文讨论了最知名的膜成分,即脂多糖、蛋白I、蛋白II、蛋白III和菌毛的结构、抗原性及功能。脂多糖是一种强免疫原,可诱导杀菌抗体,但因其毒性不适用于疫苗。蛋白I和蛋白III是稳定蛋白,不会发生抗原变异。在播散性淋球菌感染患者的血清中可检测到能杀死淋病奈瑟菌的抗蛋白I抗体。蛋白II和菌毛是高度可变的抗原,具有恒定的、免疫原性非常弱的区域。为在不同阶段阻断淋球菌感染的发病机制,未来的疫苗应包含不止一种表面抗原。